The Impact of Obesity on Pain Perception During and After Subcutaneous Injections: A Cross-Sectional Analysis
Obesities · 02.11.2024 · 4 (4) · 438-452
DOI: 10.3390/obesities4040035 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Obesities, online erschienen am 02.11.2024. Verfasst von Candelaria de la Merced Díaz-González und 2 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
The administration of subcutaneous (SC) injectables is among the most frequent procedures a nurse performs in daily practice. The needle for the injection must pass through the skin barrier to reach the SC space, where the drug will be deposited. This procedure can cause pain to the patient and local lesions. Local fat measurement can be performed by measuring the skin fold. Previous studies have found higher levels of pain in people with obesity receiving SC insulin, and this study thus aimed to measure pain levels during and after an SC injection of low-molecular-weight heparin (LMWH) and identify how age, gender, and obesity may modulate the level of pain during and after the procedure. (2)
Methods
This was a cross-sectional study, and the variables included age, gender, body mass index (BMI), BMI quartile, abdominal skin folds (ASFs), ASF quartile, and pain level during and after injection. A caliper was used to measure ASFs, height and weight were used to calculate BMI, and the Visual Analog Scale (VAS) was used to measure pain. (3)
Results
The sample amounted to 202 participants, which was not considered representative of the study population. The average age was 64.3 years, and females predominated (62.40%). Of these participants, 42.5% were obese, and 29.1% were overweight. The average pain levels were low during (1.4) and after injection (1.9), highlighting the absence of pain during injection in 29.7% and after injection in 34.2%. (4)
Conclusions
Obesity was associated with increased pain, but when adjusted for age, the pain was no longer significant. Females and young participants showed a significant relationship with pain during injection. Age, gender, and obesity had a statistically significant relationship with pain level. Participants with obesity (according to BMI and ASF) showed the highest levels of pain during and after injection. After injection, there was an increase in pain in most cases, possibly due to the discomfort caused by the drug itself, an aspect considered in the drug’s technical data sheet as a frequent adverse effect (>1/10 to
Zitieren
APA
Díaz-González, C. D. L. M., Ramal-López, J. M., & Rosa-Hormiga, M. D. L. (2024). The Impact of Obesity on Pain Perception During and After Subcutaneous Injections: A Cross-Sectional Analysis. Obesities, 4(4), 438-452. https://doi.org/10.3390/obesities4040035
Vancouver
Díaz-González CDLM, Ramal-López JM, Rosa-Hormiga MDL. The Impact of Obesity on Pain Perception During and After Subcutaneous Injections: A Cross-Sectional Analysis. Obesities. 2024;4(4):438-452. doi:10.3390/obesities4040035
BibTeX
@article{DazGonzlez2024,
author = {Díaz-González, Candelaria de la Merced and Ramal-López, Josefa María and Rosa-Hormiga, Milagros de la},
title = {The Impact of Obesity on Pain Perception During and After Subcutaneous Injections: A Cross-Sectional Analysis},
journal = {Obesities},
year = {2024},
volume = {4},
number = {4},
pages = {438--452},
doi = {10.3390/obesities4040035}
}
EUVIMED